Zobrazeno 1 - 10
of 181
pro vyhledávání: '"K Kolarić"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Z. Mechl, K. Kolarić
Publikováno v:
Oncology. 48:93-96
On the basis of results obtained with oral idarubicin administration in breast cancer, which have shown an established antitumor activity in approximately 28% of cases, this compound was combined with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::499de41aa7235f1a71d98ef66d63cfa3
https://doi.org/10.1159/000226903
https://doi.org/10.1159/000226903
Publikováno v:
Tumori Journal. 76:51-53
Forty-four patients with advanced gastric cancer were treated with a combination including 5-fluorouracil, 4-epi-doxorubicin and mitomycin C. 4-Epi-doxorubicin was substituted for adriamycin in MacDonald's original schedule. The combined treatment in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f8334a36ff663dbff6a3853dc088a3
https://doi.org/10.1177/030089169007600113
https://doi.org/10.1177/030089169007600113
Autor:
K, Kolarić, Z, Mechl
Publikováno v:
Oncology. 48(2)
On the basis of results obtained with oral idarubicin administration in breast cancer, which have shown an established antitumor activity in approximately 28% of cases, this compound was combined with cyclophosphamide (also given orally) in postmenop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32bd0068c15c19c5994a6d8eb3575e6e
https://pubmed.ncbi.nlm.nih.gov/1997944
https://pubmed.ncbi.nlm.nih.gov/1997944
Autor:
D. Vukas, K. Kolarić
Publikováno v:
Cancer chemotherapy and pharmacology. 27(5)
Due to the favourable results previously obtained with cisplatin in breast cancer (54% response rate), we studied a second-generation platinum analogue, carboplatin, in patients with previously untreated breast cancer. A total of 20 patients were ent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13df7cca12d1db3ffe33ffe23ecd3525
https://pubmed.ncbi.nlm.nih.gov/1999004
https://pubmed.ncbi.nlm.nih.gov/1999004
Publikováno v:
Journal of Clinical Oncology. 25:4565-4565
4565 Background: To compare the treatment results chemoradiotherapy that include split-course radiotherapy versus continuous radiotherapy for patients with locoregional advanced unresectable esophageal cancer. Methods: The randomized clinical study i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b2578598c32f30eea0af85c7857e943
https://doi.org/10.1200/jco.2007.25.18_suppl.4565
https://doi.org/10.1200/jco.2007.25.18_suppl.4565
562 High doses of epirubicin and 5-fluorouracil with or without cisplatin in advanced gastric cancer
Publikováno v:
European Journal of Cancer. 31:S120
From Sept. 1991. to Jan. 1995. 80 pts. with advanced gastric cancer entered phase III clinical trial. The aim of the study was to determine activity of high doses of 5-fluorouracil and epirobicin (FE) vs. the same combination + cisplatin (FEP) in tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56cee6d23ec1d1d1231351be64b18cc5
https://doi.org/10.1016/0959-8049(95)95816-o
https://doi.org/10.1016/0959-8049(95)95816-o
Publikováno v:
European Journal of Cancer. 29:S153
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b036a9aa0144b1bf76e37caf73eaf442
https://doi.org/10.1016/0959-8049(93)91469-2
https://doi.org/10.1016/0959-8049(93)91469-2
Publikováno v:
European Journal of Cancer. 29:S74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10d909c5fb3f0bc0feb017fe13c7c7f4
https://doi.org/10.1016/0959-8049(93)91006-7
https://doi.org/10.1016/0959-8049(93)91006-7
Autor:
K Kolarić
Publikováno v:
Zeitschrift für Krebsforschung und Klinische Onkologie. 89:311-319
Twenty-four patients with far advanced malignant tumors, resistent to established chemotherapy,, were treated with the combination of MNU and Cyclophosphamide. The drugs were administered in six-day cycles sequentially. MNU in doses of 4 mg/kg body w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad5a04fb426455e07f90b9007dae967e
https://doi.org/10.1007/bf00283785
https://doi.org/10.1007/bf00283785